Renal microvascular dysfunction, hypertension and CKD progression.
about
Intraoperative hypotension - a neglected causative factor in hospital-acquired acute kidney injury; a Mayo Clinic Health System experience revisitedRenal autoregulation in health and diseaseGlomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophyInhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive ratsDevelopmental Origins and Nephron Endowment in HypertensionRole of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout miceHemodynamic basis for the limited renal injury in rats with angiotensin II-induced hypertension.Arterial Stiffness, Kidney Function, and Chronic Kidney Disease ProgressionCompetitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.Experimental coronary artery stenosis accelerates kidney damage in renovascular hypertensive swine.Renal perfusion index reflects cardiac systolic function in chronic cardio-renal syndrome.The Pivotal Role of a Novel Biomarker of Reactive Oxygen Species in Chronic Kidney DiseaseRole of 24-h ambulatory blood pressure monitoring in children with chronic kidney disease.Klotho Ameliorates Kidney Injury and Fibrosis and Normalizes Blood Pressure by Targeting the Renin-Angiotensin System.Pentosan polysulfate preserves renal microvascular P2X1 receptor reactivity and autoregulatory behavior in DOCA-salt hypertensive ratsChronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adultsEffect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial.Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular HypertensionBlood pressure-renal blood flow relationships in conscious angiotensin II- and phenylephrine-infused ratsIncreased Blood Pressure Variability Prior to Chronic Kidney Disease Exacerbates Renal Dysfunction in Rats.Nephrosclerosis: update on a centenarian.High serum creatinine nonlinearity: a renal vital sign?Cumulative Exposure to Systolic Blood Pressure During Young Adulthood Through Midlife and the Urine Albumin-to-Creatinine Ratio at Midlife.Hypertension in Chronic Kidney Disease.Management of Hypertension in Patients with Chronic Kidney Disease.Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced FibrosisSex-linked differences in the course of chronic kidney disease and congestive heart failure: a study in 5/6 nephrectomized Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula.Relation of Renal Function with Left Ventricular Systolic Function and NT-proBNP Level and Its Prognostic Implication in Heart Failure with Preserved versus Reduced Ejection Fraction: an analysis from the Korean Heart Failure (KorHF) Registry.Evaluation of Renal-Hepatic Functional Indices and Blood Pressure Based on the Progress of Time in a Rat Model of Chronic Kidney DiseaseSPS3 Evidence Supports Intensive Blood Pressure Control.Hypertensive renal injury is associated with gene variation affecting immune signaling.Personalized evaluation based on quantitative proteomics for drug-treated patients with chronic kidney disease.Relationship between diurnal blood pressure and renal histopathological changes in white coat hypertension.Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc Analysis of the SPRINT Trial.P2 receptors in renal autoregulation.Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways.Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease.Renal autoregulation and blood pressure management in circulatory shock.Risk factors of renal dysfunction and their interaction in level-low lead exposure paint workers.
P2860
Q26782796-8749BB05-8BEF-4ABE-92FE-DB877780C9BEQ28082365-08ED7DFA-53DB-4468-A613-4C0F394CB0D5Q28608232-DAA64DE1-0C25-4B54-843A-E1D1847A4EB0Q28659091-C9B5EE17-C507-4E5F-8AEF-DDD98689EC82Q33849551-4898C766-7155-49A5-AD39-E5C8CCB62369Q34412951-280A2F50-4F78-408F-A119-FCA734836601Q35035267-AB84A8D8-17BA-48AA-867E-37AAD5CD562BQ35043157-E770108D-6ACD-416D-AC03-5A9615354E93Q35228536-258C2DCE-A1A6-404C-A1DD-090B3C0A946CQ35243364-EFCCBD2D-A2FB-4460-ADFA-3961507D9991Q35545665-7630776D-3485-49B4-B754-DC9E4A960519Q35857985-747A2DAA-17E3-4711-8EEA-19F707744B3EQ36330458-F592059F-EA00-4090-9E6B-63AF06F87AFDQ36509091-6BEB2BB9-DBD4-4DDC-B094-AC69283D4D96Q36698733-3E68914D-F73B-4580-B884-BC36298A204CQ36758800-0410057D-3FC4-4E61-878C-339CCD1A7F9BQ36791014-2F0D5835-E070-4F9E-8C49-3F9004307C4AQ36991756-1ABF0B40-4671-4359-A0C1-71C7EE79B2A8Q37234782-F612711C-1BAC-48C4-B481-39D5A10DFF0DQ37277486-9944EB8B-6A8A-4487-A82F-FFAD2D3C627AQ38285618-84E51782-C381-4EBC-9E9B-620FCE742F5DQ38838110-277608C5-36A1-429D-A47F-82B2994315A4Q38879739-4793B51D-4703-46F3-93A8-5A1083A78F6AQ39165623-2FC14698-EB0C-4553-BD1D-CE352737D89CQ39268835-4A52C5B2-9A89-4F88-8A83-D04DC0F8E241Q39464387-4D88389F-E3D3-464B-88D5-3FF6D74D5A60Q40664180-6F6C7DE0-592A-4B8B-9996-C2CB28C04243Q41686272-2051638D-4E6C-4F5E-8CEC-BF320590D943Q42359423-5FA89753-6549-421B-BEFF-45EB3E9EEC3CQ42381475-0B44522E-3BD7-429F-9705-0D6C3AAE2322Q43071752-AC498D60-25B0-4DB6-8A00-6564D90050D1Q47324570-6CD101CC-8B1C-405C-8DF8-FACB5E8AD433Q47831129-2EF12131-C800-44D6-BB96-3D5B1A667817Q47849866-644A4C17-3BF1-4455-8EF2-7942C2DB915AQ49289428-B45E2E24-8B31-4AD5-88B5-38F73AEA56F3Q51741240-F8B80357-123C-4725-AB62-35C2C19F7E34Q53128566-61682F86-5536-40E7-89EB-E0DB0235D423Q53764059-2A57953F-3623-41E0-8CFA-7B33CF16CA5DQ55048418-E54BFC98-6FE1-4B5F-A989-83168F3DB056Q55332202-B79027E2-BCB7-45D5-A663-21727C90DDDE
P2860
Renal microvascular dysfunction, hypertension and CKD progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Renal microvascular dysfunction, hypertension and CKD progression.
@en
Renal microvascular dysfunction, hypertension and CKD progression.
@nl
type
label
Renal microvascular dysfunction, hypertension and CKD progression.
@en
Renal microvascular dysfunction, hypertension and CKD progression.
@nl
prefLabel
Renal microvascular dysfunction, hypertension and CKD progression.
@en
Renal microvascular dysfunction, hypertension and CKD progression.
@nl
P2093
P2860
P1476
Renal microvascular dysfunction, hypertension and CKD progression.
@en
P2093
Aaron J Polichnowski
Anil K Bidani
Karen A Griffin
Rodger Loutzenhiser
P2860
P356
10.1097/MNH.0B013E32835B36C1
P577
2013-01-01T00:00:00Z